Radhakishan Damani stocks: In the special edition of The Big Bulls Portfolio show, Zee Business research analysts' panel discusses the stocks from which ace investor Radhakishan Damaniearned huge returns.  

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Billionaire investor and India’s eighth richest on the Forbes list, Radhakishan Damani holds a portfolio of over 20 stocks from pharma to finance space. One of the Big Bulls of the Indian stock market, Damani is a promoter of retail chain Avenue Supermarts of the D-Mart chain.  

Tradeswift's Sandeep Jain while speaking about the huge gains these investors make from the market, mentions three things in common among them when they invest in any stock: Conviction, Discipline, and Research. They follow a single pattern of Buy, Hold and Forget strategy.  

See Zee Business Live TV Streaming Below:

Metropolis Healthcare

Amid rising covid cases and testing, Diagnostic companies have seen a huge surge lately. In this regard, Zee Business Research Analyst Devanshi Ashar points out we have seen a similar boom in Metropolis Healthcare. Stating the fundamentals of this company being strong, Ashar says that this company works on the asset-light model. 

In April 2019, Damani had purchased 7 lakh shares for Rs 65-66 crore and eventually has doubled his holding to 14 lakh shares or a 7.4 per cent stake which amounts to Rs 201 crore holding, explains Ashar. 

Sundaram Finance 

This NBFC company is one of the favourites of Damani, he has been holding this stock for over 10 years now, says Ashar. He purchased the 1.3 per cent stake in this company at Rs 140 apiece, the stock today has risen to Rs 2557 per equity share. Its current valuation is at Rs 671 crore, adds Ashar. 

Sundaram Finance is into financing business, it allots commercial and various types of loans in the market. Its fundamentals are strong and the company has AUM of over Rs 3100 crore, Ashar says. 

Tradeswift’s Director Sandeep Jain being bullish about the diagnostic companies says, both of these Damani holdings have seen quite a good bull run. He suggests, fresh investors to wait for some correction in both the stocks and then purchase. However, he has put a 'hold' rating for all those who have invested in them already. Jain sets a target of Rs 2490 per share and Rs 2870 per share for Metropolis Healthcare and Sundaram Finance respectively.  

(Authored by Vaibhav Bansode)